Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Shield

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Clinical Transplantation|March 21, 2002
IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotypeC F Bryan, J Martinez, N Muruve, et al.
Transplantation Proceedings|March 20, 1999
Influence of an historically positive crossmatch on cadaveric renal transplantationC F Bryan, C F Shield, B A Warady, et al.
Kidney International|March 1, 1996
OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survivalD Abramowicz, D J Norman, P Vereerstraeten, et al.
Transplantation|January 12, 1999
Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneysC F Bryan, C F Shield, P W Nelson, et al.
Transplantation|March 21, 1998
Influence of the Rh (D) blood group system on graft survival in renal transplantationC F Bryan, S I Mitchell, H M Lin, et al.
Transplantation|February 11, 1998
Ten-year experience in transplantation of A2 kidneys into B and O recipientsP W Nelson, M D Landreneau, A M Luger, et al.
Transplantation Proceedings|February 1, 1996
Evaluation of the 3.0 Ortho EIA assay in 385 consecutive cadaveric organ donorsC F Bryan, G E Tegtmeier, A Polito, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Clinical Transplantation|March 21, 2002
IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotypeC F Bryan, J Martinez, N Muruve, et al.
Transplantation Proceedings|March 20, 1999
Influence of an historically positive crossmatch on cadaveric renal transplantationC F Bryan, C F Shield, B A Warady, et al.
Kidney International|March 1, 1996
OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survivalD Abramowicz, D J Norman, P Vereerstraeten, et al.
Transplantation|January 12, 1999
Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneysC F Bryan, C F Shield, P W Nelson, et al.
Transplantation|March 21, 1998
Influence of the Rh (D) blood group system on graft survival in renal transplantationC F Bryan, S I Mitchell, H M Lin, et al.
Transplantation|February 11, 1998
Ten-year experience in transplantation of A2 kidneys into B and O recipientsP W Nelson, M D Landreneau, A M Luger, et al.
Transplantation Proceedings|February 1, 1996
Evaluation of the 3.0 Ortho EIA assay in 385 consecutive cadaveric organ donorsC F Bryan, G E Tegtmeier, A Polito, et al.
Pageof 9